January 12-15, 2026 | San Francisco Marriott Marquis, CA
Peptron is a pre-clinical to commercial-stage Biotech company in Korea, which has been dedicated to developing Long-acting Injectable (LAI) formulation platform technologies for peptide-based therapeutics, and therapeutic antibody programs.